Olaparib+Trastuzumab in HER2[+],Breast Cancer Susceptibility Gene (BRCA) Mutated Advanced Breast Cancer
Status: TERMINATED
Study type: INTERVENTIONAL
Conditions: Advanced Breast Cancer
Interventions: DRUG: Olaparib [Lynparza®] plus Trastuzumab [Herceptin®]
Sponsor: MedSIR